MARKET

BDRX

BDRX

Biodexa Pharmaceuticals plc
NASDAQ
2.365
-0.035
-1.46%
Opening 13:01 11/12 EST
OPEN
2.350
PREV CLOSE
2.400
HIGH
2.430
LOW
2.304
VOLUME
10.52K
TURNOVER
--
52 WEEK HIGH
357.60
52 WEEK LOW
2.280
MARKET CAP
1.24M
P/E (TTM)
-4.4555
1D
5D
1M
3M
1Y
5Y
1D
Biodexa Reports Serenta Trial Two-Thirds Enrolled, MTX240 Preparations Advance
TipRanks · 3d ago
Biodexa Pharma Announces Further Progress In Both Its Lead Programs; eRapa For Familial Adenomatous Polyposis And MTX240 Molecular Glue For Gastrointestinal Stromal Tumors
Benzinga · 3d ago
Weekly Report: what happened at BDRX last week (1102-1106)?
Weekly Report · 3d ago
Short Interest Alert: Most and least shorted sub-$2B healthcare stock at the end of October
Seeking Alpha · 11/03 15:15
Weekly Report: what happened at BDRX last week (1026-1030)?
Weekly Report · 11/02 09:54
Biodexa Pharmaceuticals Plc - Depositary Receipt Price Target Increased by 700.00% to $73.44
NASDAQ · 11/02 04:12
Stock Splits on Deck This Week (October 26 to October 30) – Stay Invested
TipRanks · 10/26 13:06
Weekly Report: what happened at BDRX last week (1019-1023)?
Weekly Report · 10/26 09:54
More
About BDRX
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.

Webull offers Biodexa Pharmaceuticals PLC-ADR stock information, including NASDAQ: BDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDRX stock methods without spending real money on the virtual paper trading platform.